Key takeaways:
Spiriva (tiotropium) is an inhaled medication that comes in HandiHaler and Respimat devices. They both treat chronic obstructive pulmonary disease (COPD), but Spiriva Respimat also treats asthma.
Spiriva HandiHaler comes as a brand name and generic product. Spiriva Respimat doesn’t have a generic available yet.
There are several ways to save on Spiriva. Manufacturer savings cards and patient assistance programs are available. GoodRx can also help you access the generic version, tiotropium, at exclusive cash prices.
Managing chronic obstructive pulmonary disease (COPD) can be tricky. Many of the medications used to treat COPD, like Spiriva Respimat (tiotropium), are brand-name inhalers without generic alternatives available. While these are effective medications that help improve breathing, lung function, and quality of life, cost can sometimes be a barrier.
Thankfully, there’s good news. If you or a loved one are looking to fill a prescription for Spiriva, there are steps you can take to make your trip to the pharmacy more affordable.
Spiriva is a long-acting, prescription-only inhaler. It makes it easier to breathe by relaxing the airways in your lungs. Taken as two puffs once a day, Spiriva aims to manage and control your breathing symptoms over time.
There are two kinds of Spiriva inhalers available for use:
Spiriva HandiHaler: This is a capsule-based inhaler that’s FDA approved to treat COPD. To use it, you breathe in a dry powder that comes from a capsule. The HandiHaler device pierces the capsule, and then you inhale the dry powder through the mouthpiece. Do not swallow the capsule whole.
Spiriva Respimat: This is an inhalation spray that’s approved to treat COPD and asthma. The Respimat device delivers medication as a fine mist from a prefilled cartridge. To use the medication, you load the medication cartridge into the device and press a button to release the mist through the mouthpiece.
The active ingredient in Spiriva, tiotropium, is also found in combination inhalers. For instance, Stiolto Respimat (tiotropium/olodaterol) is a different COPD inhaler that combines two medications into one device.
Spiriva works by binding to receptors (chemical binding sites) in the lungs called muscarinic receptors. This relaxes smooth muscles in the airways of your lungs, making it easier to breathe.
These effects tend to last over time. Spiriva is dosed once daily because it’s a long-acting inhaler. It can relax the airways in your lungs for up to 24 hours at a time. When used consistently, this helps control COPD symptoms and decreases the likelihood of COPD exacerbations (flare-ups).
Spiriva is an effective option for treating COPD. Clinical guidelines suggest that long-acting inhalers like Spiriva are key to preventing and managing COPD symptoms over time. Other possible benefits include:
Fewer COPD exacerbations
Decreased shortness of breath
Improved lung function and overall health
More effective pulmonary rehabilitation treatments
What’s more, Spiriva HandiHaler and Spiriva Respimat both appear to be well-tolerated. One isn’t considered more effective than the other, either.
When you go to the pharmacy to fill your prescription, it’s common to receive either a 30-day or 90-day supply of medication. For a 30-day supply of brand-name Spiriva HandiHaler, the retail price can range from about $550 to $700. The generic HandiHaler tends to cost $500 to $550. The average retail price for a 30-day supply of Spiriva Respimat is about $651.48.
Yes — for one version of Spiriva. A generic version of Spiriva HandiHaler launched in the U.S. in August 2023. It’s now available for use.
Spiriva Respimat does not have a generic version available yet. A generic may not be available for another few years.
There are ways to save on Spiriva, which is available as a brand-name and generic medication. GoodRx can help you navigate between GoodRx coupons, copay savings cards, and patient assistance programs to save money on your prescription.
Save with GoodRx: Anyone with a valid prescription, regardless of insurance status, can use GoodRx to purchase a 30-day supply of generic tiotropium at an exclusive cash price, which ranges from $75 to $365 — prices vary by pharmacy.
Save with a copay savings card: If you have commercial insurance, you may be eligible to pay as little as $35 for Spiriva HandiHaler or Sprivia Respimat using a savings card from the manufacturer. A $25 savings card is available for the generic version of Spiriva HandiHaler, too.
Save with patient assistance programs: If you’re uninsured or underinsured, you may be eligible for Spiriva’s patient assistance program, which offers the medication free of charge.
Another option is talking to your healthcare provider to see if there are any other COPD medications that might work for you. It’s important to have an open, honest conversation with your healthcare provider about prescription costs.
If your prescription insurance denies coverage for Spiriva, your healthcare provider may also be able to submit an appeal or prior authorization. Each insurance plan’s appeal process can be different. But if Spiriva is the best choice for your situation, talk to your healthcare provider to see if this approach might be an option for you.
There are ways to save on brand name and generic Spiriva, including free GoodRx coupons, copay savings cards, and patient assistance programs. If you’re having trouble accessing Spiriva, be sure to talk to your healthcare provider or pharmacist to see if they can connect you to other ways to save.
Delgado, B. J., et al. (2022). Tiotropium. StatPearls.
Dunleavy, K. (2023). Lupin wins approval for first US generic of Boehringer Ingelheim's COPD blockbuster Spiriva. Fierce Pharma.
Global Initiative for Chronic Obstructive Lung Disease. (2023). Global strategy for prevention, diagnosis, and management of COPD: 2023 report.
Lupin Pharmaceuticals. (2023). Lupin launches tiotropium dry powder for inhaler for the treatment of COPD in the United States. PR Newswire.
Oba, Y., et al. (2008). Safety, tolerability and risk benefit analysis of tiotropium in COPD. International Journal of Chronic Obstructive Pulmonary Disease.
van Noord, J. A., et al. (2009). The efficacy of tiotropium administered via respimat soft mist inhaler or HandiHaler in COPD patients. Respiratory Medicine.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.